Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.

NCT00216242 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

7400

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza virus vaccine (Fluviral)
BIOLOGICAL: Saline placebo

Sponsor

ID Biomedical Corporation, Quebec